KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortization - Intangibles: 2018-2024

Historic Amortization - Intangibles for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Dec 2024 value amounting to $78.0 million.

  • Supernus Pharmaceuticals' Amortization - Intangibles rose 24.74% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.2 million, marking a year-over-year increase of 2.95%. This contributed to the annual value of $78.0 million for FY2024, which is 5.34% down from last year.
  • According to the latest figures from FY2024, Supernus Pharmaceuticals' Amortization - Intangibles is $78.0 million, which was down 5.34% from $82.4 million recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Amortization - Intangibles ranged from a high of $82.6 million in FY2022 and a low of $15.7 million during FY2020.
  • Its 3-year average for Amortization - Intangibles is $81.0 million, with a median of $82.4 million in 2023.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Amortization - Intangibles surged by 201.96% in 2020 and then dropped by 5.34% in 2024.
  • Supernus Pharmaceuticals' Amortization - Intangibles (Yearly) stood at $15.7 million in 2020, then soared by 91.06% to $30.0 million in 2021, then surged by 175.43% to $82.6 million in 2022, then fell by 0.28% to $82.4 million in 2023, then declined by 5.34% to $78.0 million in 2024.